Ohki Healthcare Holdings Co.,Ltd. (TYO:3417)

Market Cap	17.88B +60.3%
Revenue (ttm)	359.41B +4.0%
Net Income	2.43B +4.2%
EPS	178.43 +4.3%
Shares Out	13.64M
PE Ratio	7.35
Forward PE	n/a
Dividend	28.00 (2.11%)
Ex-Dividend Date	Mar 30, 2026

Volume	5,500
Average Volume	18,665
Open	1,291.00
Previous Close	1,311.00
Day's Range	1,291.00 - 1,328.00
52-Week Range	655.00 - 1,472.00
Beta	0.54
RSI	30.52
Earnings Date	Feb 5, 2026

About Ohki Healthcare Holdings

Ohki Healthcare Holdings Co.,Ltd. engages in the manufacture and sale of pharmaceuticals and other products. The company is involved in the sale, import, and export of pharmaceuticals, quasi-drugs, medical equipment, cosmetics, poisons, deleterious substances, chemicals, reagents, measuring instruments, optical equipment, electrical appliances, and communication equipment; and veterinary drugs, veterinary quasi-drugs, veterinary medical equipment, pet supplies, feed, and feed additives. It also sells, imports, and exports textile products, hygi...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1658
• Employees: 648
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3417

Financial Performance

In fiscal year 2025, Ohki Healthcare Holdings's revenue was 349.45 billion, an increase of 4.42% compared to the previous year's 334.66 billion. Earnings were 2.64 billion, an increase of 19.41%.